Clinical Trials List
Protocol NumberCICL670A2214
Completed
2011-01-01 - 2014-12-31
Phase II
Terminated1
ICD-10E83.10
Disorder of iron metabolism, unspecified
ICD-10E83.110
Hereditary hemochromatosis
ICD-10E83.111
Hemochromatosis due to repeated red blood cell transfusions
ICD-10E83.118
Other hemochromatosis
ICD-10E83.119
Hemochromatosis, unspecified
ICD-10E83.19
Other disorders of iron metabolism
ICD-9275.0
Disorders of iron metabolism
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3 participants
-
Global
45 participants
